Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3034099	li-cmvab	— (—)	73	77	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other bacterial diseases

6.94

17.70

1.1

1.0

—

ILD medications: immunosuppressive drugs

7.74

17.55

1.1

—

Other bacterial diseases

6.35

16.49

1.1

1.0

—

Pneumonia, organism unspecified

6.35

15.22

1.0

1.1

—

Oral corticosteroids

5.76

14.69

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5.71

14.61

1.0

1.1

—

Bacterial infection, other or unspecified

11.42

14.29

1.1

—

Inflammatory bowel disease treatment related agents

5.28

13.61

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

5.30

13.08

1.0

1.1

—

Influenza and pneumonia

5.19

12.93

1.0

1.1

—

All pneumoniae

5.14

12.67

1.0

1.1

—

Bacterial infection, other or unspecified

10.42

12.32

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

5.41

12.31

1.1

—

Second line medication for Crohn's disease

5.68

11.45

1.0

1.1

—

L04AX Other immunosuppressants

5.68

11.45

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

4.95

10.81

1.1

—

ILD medications

4.78

10.78

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5.25

10.76

1.0

1.1

—

5.25

10.76

1.0

1.1

—

Fever of other and unknown origin

8.19

10.51

1.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4.54

10.16

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

4.93

10.06

1.1

—

Disorders of lens

5.70

9.53

1.0

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

15.02

9.50

1.0

—

Persons encountering health services for specific procedures and health care

4.20

9.13

1.1

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

4.22

8.97

1.0

1.1

—

Liquid cancers, helper endpoint

8.27

8.38

1.0

1.1

—

Senile cataract

5.54

8.35

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4.60

7.97

1.0

1.1

—

Epilepsy

9.98

7.50

1.1

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

13.35

7.37

1.0

—

Presence of other functional implants

5.13

7.32

1.0

—

Other and unspecified polyneuropathies, also in other diseases

12.02

7.07

1.0

—

Visual disturbances and blindness

5.59

7.04

1.1

—

First line medication for Crohn's disease

3.93

7.00

1.0

1.1

—

Autoimmune diseases related-to ILD

3.82

6.94

1.0

1.1

—

Focal epilepsy

13.76

6.88

1.1

1.0

—

Pure hypercholesterolaemia

4.82

6.72

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

3.80

6.64

1.0

1.1

—

Cerebrovascular diseases

4.17

6.58

1.1

—

Low back pain

4.13

6.56

1.1

—

Implicit viral Sepsis

14.30

6.39

1.1

1.0

—

Viral Sepsis

14.30

6.39

1.1

1.0

—

Implicit Sepsis

3.98

6.37

1.1

—

Implicit Sepsis

3.75

6.15

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

12.51

6.07

1.1

1.0

—

Focal epilepsy, strict definition

12.51

6.07

1.1

1.0

—

Oedema, not elsewhere classified

9.87

5.97

1.1

1.0

—

Other septicaemia

7.35

5.93

1.1

1.0

—

Metabolic disorders

3.81

5.92

1.1

—

General symptoms and signs

3.90

5.91

1.0

—

Cerebrovascular diseases (FINNGEN)

11.12

5.84

1.2

1.1

—

Other disorders of lacrimal gland

8.00

5.83

1.0

1.1

—

Other neurological diseases

3.82

5.82

1.0

1.1

—

Heart failure, not strict

3.79

5.81

1.0

1.1

—

L04AA Selective immunosuppressants

11.12

5.79

1.0

—

Diagnoses used for exclusion with ILD

9.17

5.78

1.1

1.0

—

Any death

4.06

5.75

1.0

1.1

—

Type 2 diabetes, wide definition

3.97

5.70

1.0

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

4.21

5.70

1.1

—

Implicit bacterial Sepsis

6.21

5.63

1.1

1.0

—

Septicaemia

6.76

5.61

1.1

—

Bacterial pneumoniae

7.56

5.52

1.0

1.1

—

Autoimmune diseases

3.50

5.45

1.0

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

16.02

5.41

1.0

—

Disorders of lacrimal system

6.18

5.36

1.0

—

Explicit Sepsis

5.69

5.36

1.1

1.0

—

Implicit bacterial Sepsis

5.76

5.33

1.1

1.0

—

Sleep apnoea

3.24

5.33

1.1

1.0

—

Mycoses

9.10

5.28

1.1

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3.25

5.15

1.1

1.0

—

Implicit viral Sepsis

7.34

5.13

1.1

1.0

—

Bacterial Sepsis

5.44

5.11

1.1

1.0

—

Visual disturbances

4.84

5.10

1.0

1.1

—

Certain disorders involving the immune mechanism

13.34

5.07

1.1

1.0

—

Bacterial pneumonia, not elsewhere classified

7.45

5.06

1.0

1.1

—

Disorders of choroid and retina

3.38

5.05

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.35

4.99

1.1

—

Polyarthropathies

3.70

4.99

1.0

1.1

—

Diabetes, varying definitions

3.24

4.95

1.0

1.1

—

Certain infectious and parasitic diseases

4.22

4.95

1.1

—

Diabetes mellitus

3.23

4.92

1.0

1.1

—

COPD/asthma/ILD related infections

3.34

4.66

1.1

—

COPD/asthma related infections

3.34

4.66

1.1

—

Symptoms and signs involving speech and voice

7.15

4.64

1.0

1.1

—

Renal tubulo-interstitial diseases

3.04

4.61

1.0

1.1

—

Type 2 diabetes

3.16

4.55

1.1

—

Neurological diseases

5.94

4.54

1.1

1.0

—

Codes for special purposes

4.51

4.53

1.1

1.0

—

Provisional assignment of new diseases of uncertain etiology

4.51

4.53

1.1

1.0

—

Other cataract

5.68

4.50

1.1

—

Other viral diseases

6.65

4.45

1.1

—

Dorsalgia

3.15

4.41

1.1

—

Other viral diseases

5.75

4.40

1.1

—

Asthma (mode)

4.16

4.40

1.1

—

Sleep apnoea, including avohilmo

2.96

4.40

1.1

1.0

—

Other symptoms and signs involving cognitive functions and awareness

5.20

4.37

1.1

—

Bacterial pneumonia (organism specified)

5.18

4.36

1.0

1.1

—

Headache

4.47

4.35

1.0

—

Candidiasis

7.50

4.35

1.1

—

Care involving use of rehabilitation procedures

4.06

4.34

1.1

1.0

—

4.61

4.32

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.88

4.31

1.0

1.1

—

Stroke, excluding SAH

3.53

4.30

1.1

—

Asthma-related infections

3.34

4.30

1.0

—

Asthma, hospital admission 2, infections

3.34

4.30

1.0

—

L04AD Calcineurin inhibitors

11.68

4.27

1.1

1.0

—

Biological medication for rheuma

11.68

4.27

1.0

—

Asthma

4.08

4.26

1.1

—

Stroke, including SAH

3.51

4.26

1.1

—

Episodal and paroxysmal disorders

3.08

4.20

1.1

1.0

—

Asthma-related pneumonia

5.23

4.13

1.0

—

Asthma, hospital admissions 3, pneumonia

5.23

4.13

1.0

—

Asthma-related pneumonia or sepsis

5.23

4.13

1.0

—

Asthma, excluding more controls

4.56

4.07

1.1

—

Other diseases of blood and blood-forming organs, wide

8.00

4.05

1.1

1.0

—

Dysphagia

8.00

4.05

1.0

1.1

—

Other disorders of urethra and urinary system

3.38

4.05

1.1

—

Diabetes medication

2.89

4.01

1.1

—

Other skin changes

10.01

4.01

1.1

1.0

—

Covid-19 confirmed case

5.00

3.99

1.2

1.0

—

STROKE

4.14

3.96

1.1

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.07

3.96

1.0

1.1

—

Asthma, unspecified (mode), excluding more controls

5.14

3.89

1.1

—

Malignant neoplasm

3.14

3.88

1.0

1.1

—

Acute and subacute iridocyclitis

7.28

3.85

1.1

1.0

—

Anterior Iridocyclitis

7.28

3.85

1.1

1.0

—

Malaise and fatigue

4.92

3.81

1.1

—

Other intervertebral disc disorders

3.21

3.79

1.0

1.1

—

Methotrexate

12.01

3.76

1.0

—

Candidiasis

12.01

3.76

1.2

1.0

—

Chronic kidney disease

5.16

3.75

1.0

—

Renal failure

3.96

3.74

1.0

—

Dizziness and giddiness

3.13

3.71

1.0

1.1

—

Intracranial trauma

6.33

3.69

1.0

—

Iridocyclitis

6.67

3.67

1.1

1.0

—

Malignant neoplasm, wide definition for exclusion

3.02

3.65

1.0

1.1

—

Fall on same level

2.61

3.63

1.0

—

Organic, including symptomatic, mental disorders

4.27

3.60

1.0

1.1

—

Tramadol

3.07

3.58

1.0

1.1

—

Asthma, unspecified (mode)

4.60

3.58

1.1

—

Reimbursement for rheumatic diseases

3.49

3.58

1.0

1.1

—

Subjective visual disturbances

7.78

3.55

1.0

—

Intestinal stricture

5.30

3.50

1.0

—

Dialysis, with operation codes

10.01

3.49

1.0

—

Tumor necrosis factor alpha inhibitors

10.01

3.49

1.0

—

Lung diseases due to external agents

10.01

3.49

1.0

—

Lower back pain or/and sciatica

2.61

3.49

1.1

—

Asthma (only as main-diagnosis), excluding more controls

4.29

3.46

1.0

1.1

—

Ischaemic Stroke, excluding all haemorrhages

3.72

3.44

1.1

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

5.86

3.36

1.0

—

Sulfasalazine

5.72

3.34

1.0

1.1

—

All kidney diseases

2.60

3.32

1.0

1.1

—

Other retinal disorders

3.16

3.27

1.1

—

Persons encountering health services in other circumstances

3.91

3.26

1.0

—

All influenza

8.57

3.26

1.0

—

Mycoses

2.64

3.25

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2.77

3.22

1.1

—

All chronic kidney diseases

3.43

3.22

1.0

1.1

—

Codeine

2.80

3.18

1.0

1.1

—

Asthma (only as main-diagnosis)

3.86

3.18

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

2.61

3.16

1.1

—

Abnormal findings on diagnostic imaging of lung

3.77

3.14

1.0

1.1

—

Non-small cell lung cancer, including Hilmo

8.08

3.13

1.0

—

8.06

3.13

1.2

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.95

3.12

1.2

1.0

—

Insulin medication

3.31

3.12

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.97

3.09

1.1

—

Other medical care

4.09

3.09

1.1

1.0

—

Medical observation and evaluation for suspected diseases and conditions

3.32

3.08

1.1

—

Missing teeth due to accident, extraction or parodontitis

3.22

3.08

1.1

—

Other viral diseases, not elsewhere classified

7.48

3.05

1.0

—

Fracture of skull and facial bones

5.84

3.02

1.0

1.1

—

Allergic asthma (mode)

7.34

3.01

1.0

1.1

—

Allergic asthma (mode), excluding more controls

7.34

3.01

1.0

1.1

—

Other viral diseases, not elsewhere classified

5.80

3.00

1.0

1.1

—

Spondylopathies

2.99

3.00

1.0

1.1

—

Problems related to lifestyle

10.01

2.98

1.0

—

Nephropathy related operations

10.01

2.98

1.0

—

Herpesviral [herpes simplex] infections

10.01

2.98

1.0

—

Sarcoidosis

10.01

2.98

1.2

1.0

—

Azathioprine

10.01

2.98

1.0

—

Used for control exclusion in common control thyroid runs

2.79

2.92

1.0

1.1

—

Hypertension, essential

2.83

2.91

1.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

3.02

2.87

1.0

1.1

—

Chronic lower respiratory diseases

2.30

2.85

1.1

1.0

—

Osteopathies and chondropathies

3.19

2.85

1.1

—

Convulsions, not elsewhere classified

6.58

2.84

1.0

1.1

—

Menorrhagia

4.54

2.82

1.0

—

Codeine or tramadol medication

2.38

2.81

1.0

1.1

—

Systemic connective tissue disorders

4.45

2.79

1.0

1.1

—

Oxycodone

3.62

2.77

1.0

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.56

2.77

1.1

1.0

—

Fentanyl

8.33

2.74

1.0

—

Lung cancer and mesothelioma

6.42

2.73

1.0

—

Osteoporosis

6.23

2.72

1.0

—

Persons encountering health services in other circumstances, wide

2.30

2.71

1.0

1.1

—

Hyperlipidaemia, other/unspecified

4.33

2.70

1.0

1.1

—

Other and unspecified dermatitis

3.00

2.69

1.1

—

Caries of dentine

4.87

2.66

1.1

—

DVT of lower extremities and pulmonary embolism

3.73

2.65

1.0

1.1

—

Syncope and collapse

4.28

2.65

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

2.44

2.61

1.1

—

Non-invasive ventilation

7.44

2.55

1.2

1.0

—

Intestinal infectious diseases

2.34

2.54

1.0

1.1

—

Other/unspecified dorsalgia

3.97

2.54

1.0

1.1

—

Hypo-osmolality and hyponatraemia

7.10

2.54

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

2.60

2.51

1.2

1.0

—

Dental caries

4.49

2.50

1.1

—

Injuries to the head

2.25

2.47

1.0

1.1

—

Intestinal infectious diseases

2.26

2.46

1.0

1.1

—

Rheumatoid arthritis, including avohilmo

3.81

2.46

1.0

1.1

—

Other diseases of urinary system

2.39

2.45

1.1

—

Complications of surgical and medical care, not elsewhere classified

2.33

2.45

1.1

—

Migraine

3.47

2.42

1.0

—

Pain in throat and chest

2.50

2.41

1.0

1.1

—

Rheumatoid arthritis

3.78

2.40

1.0

1.1

—

Other dorsopathies, not elsewhere classified

2.46

2.40

1.1

—

Gastric ulcer

6.25

2.37

1.0

—

Other arthritis (FG)

4.12

2.36

1.0

1.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.04

2.35

1.0

1.1

—

Dermatitis

2.60

2.33

1.1

1.0

—

Any gastric operation

3.34

2.33

1.0

—

GASTRO-related operations

3.34

2.33

1.0

—

Cough

3.28

2.33

1.0

1.2

—

Diseases of oesophagus, stomach and duodenum

2.24

2.33

1.1

—

Other (not insulin) diabetes medications

2.37

2.32

1.1

—

Hypertensive diseases

2.55

2.30

1.0

1.1

—

Hypertension

2.55

2.30

1.0

1.1

—

Other functional intestinal disorders

3.21

2.28

1.0

1.1

—

Pulmonary heart disease

4.62

2.27

1.0

—

Pulmonary embolism

4.62

2.27

1.0

—

4.75

2.27

1.2

1.0

—

Acute tubulo-interstitial nephritis

2.59

2.25

1.0

1.1

—

Biguanides

2.32

2.24

1.1

—

Malignant neoplasm of bronchus and lung

5.93

2.23

1.0

—

Other (seronegative) rheumatoid arthritis, wide

5.56

2.21

1.0

—

Substance use, excluding alcohol

5.56

2.21

1.2

1.1

—

Acute appendicitis, with complications

5.56

2.21

1.2

1.0

—

Type 2 diabetes, definitions combined

2.38

2.19

1.1

—

Malignant neoplasm of bronchus and lung, including Hilmo

4.57

2.19

1.0

—

Obesity related asthma

3.33

2.17

1.0

1.1

—

Erysipelas

3.37

2.16

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

2.36

2.15

1.1

—

Chronic gastritis

4.29

2.15

1.0

1.1

—

Other and unspecified tonsillitis

3.36

2.14

1.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

2.32

2.08

1.1

—

2.16

2.08

1.1

—

Cellulitis

5.00

2.07

1.0

1.1

—

Type 1 diabetes

4.99

2.07

1.0

—

Insulin, intermediate and long-acting

2.70

2.05

1.1

—

Other specified/unspecified arthritis

3.50

2.05

1.0

1.1

—

Retinal detachments and breaks

3.50

2.05

1.0

1.1

—

Cervical disc disorders

3.50

2.05

1.0

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

4.00

2.03

1.0

—

Paralytic ileus and intestinal obstruction

4.00

2.03

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

3.99

2.03

1.0

1.1

—

Conjunctivitis (acute, non atopic)

3.99

2.03

1.0

1.1

—

Any event in cancer register

2.36

2.02

1.0

1.1

—

Symptoms and signs involving the urinary system

2.36

2.00

1.1

—

Hypertensive diseases (excluding secondary)

3.32

2.00

1.0

1.1

—

Other diseases of intestines

2.15

2.00

1.0

1.1

—

Hard cardiovascular diseases

2.42

1.99

1.2

1.0

—

Other disorders of eyelid

3.05

1.98

1.0

—

Aplastic and other anaemias

2.80

1.97

1.1

—

Heart failure,strict

2.89

1.96

1.0

1.1

—

Solid cancers, helper endpoint

2.40

1.95

1.0

1.1

—

Erysipelas

2.63

1.94

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3.75

1.93

1.2

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

3.75

1.93

1.2

1.1

—

Other diseases of upper respiratory tract

2.19

1.93

1.0

1.1

—

Other and unspecified anaemias

2.93

1.90

1.1

1.0

—

Other anaemias

2.92

1.89

1.1

1.0

—

Other soft tissue disorders, not elsewhere classified

2.20

1.88

1.0

1.1

—

Abdominal and pelvic pain

2.17

1.87

1.0

1.1

—

Chronic sinusitis

2.85

1.86

1.0

1.1

—

Cardiovascular diseases

2.85

1.85

1.0

1.1

—

Disorders of other endocrine glands

3.13

1.84

1.0

1.1

—

Any reimbursement code in KELA

3.51

1.84

1.0

—

Psychiatric diseases

2.21

1.82

1.1

—

Other systemic involvement of connective tissue

4.17

1.82

1.0

—

Diabetic neuropathy

4.15

1.81

1.0

1.1

—

Other heart diseases

3.26

1.81

1.0

1.1

—

Other systemic involvement of connective tissue (FG)

4.11

1.80

1.0

1.2

—

Other reaction to severe stress, and adjustment disorders

3.04

1.79

1.0

—

Inflammatory diseases of female pelvic organs

2.65

1.79

1.1

1.0

—

Dyspnoea

2.15

1.78

1.0

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

4.16

1.77

1.0

—

Other anxiety disorders

2.77

1.77

1.1

1.0

—

Abnormalities of breathing

2.20

1.76

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

2.87

1.73

1.0

1.1

—

Spinal stenosis

2.76

1.73

1.0

1.1

—

Excessive, frequent and irregular menstruation

3.20

1.72

1.0

—

Insulin, fast-acting

2.92

1.72

1.0

—

Herpesviral [herpes simplex] infections

3.85

1.71

1.0

—

Blepharochalasis

3.85

1.71

1.0

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

2.61

1.68

1.1

—

Complications of medical and surgical care

2.21

1.68

1.1

—

Finngen Rheumatological endpoints

2.15

1.68

1.0

1.1

—

Substance abuse, excluding more controls

2.51

1.66

1.1

—

Dermatitis and eczema

1.95

1.64

1.1

1.0

—

Spondylosis

2.61

1.64

1.0

1.1

—

Polyuria

3.57

1.61

1.0

—

Bronchitis

1.98

1.60

1.1

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

3.94

1.58

1.0

1.1

—

Nausea and vomiting

3.50

1.58

1.0

1.1

—

Fracture of rib(s), sternum and thoracic spine

3.00

1.58

1.0

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3.00

1.58

1.0

1.1

—

Extrapyramidal and movement disorders

2.69

1.58

1.1

1.0

—

Injuries to the knee and lower leg

1.88

1.55

1.1

1.0

—

Gingivitis and periodontal diseases

2.04

1.55

1.1

—

Temporomandibular joint disorders, including avohilmo

2.65

1.55

1.0

1.1

—

Infections of the skin and subcutaneous tissue

2.25

1.53

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

2.03

1.53

1.0

1.1

—

Asthma, including avohilmo

1.87

1.53

1.1

—

Falls/tendency to fall

2.03

1.53

1.1

—

Obesity and other hyperalimentation

2.24

1.53

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3.33

1.52

1.2

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.59

1.51

1.3

1.0

—

Insulin, fast-acting or short human

2.59

1.51

1.0

—

Viral infections characterized by skin and mucous membrane lesions

2.59

1.51

1.0

1.1

—

Leiomyoma of uterus

2.55

1.50

1.0

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.86

1.50

1.0

1.1

—

Nerve, nerve root and plexus disorders

1.92

1.49

1.0

1.1

—

Other antidepressants

1.95

1.49

1.1

—

Polycystic ovarian syndrome, consortium definition

2.37

1.49

1.1

1.0

—

Any mental disorder

1.95

1.49

1.1

—

Dementia

2.95

1.48

1.0

1.1

—

Other pulmonary diagnosis

2.50

1.48

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

2.50

1.48

1.0

1.1

—

COPD differential diagnosis

2.50

1.48

1.0

1.1

—

ILD differential diagnosis

2.50

1.48

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

2.01

1.47

1.0

1.1

—

Other acute lower respiratory infections

2.38

1.46

1.0

1.1

—

Venous thromboembolism

2.35

1.44

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

2.15

1.44

1.1

1.0

—

All-cause Heart Failure

2.35

1.43

1.0

1.1

—

Deviated nasal septum

2.72

1.43

1.0

1.1

—

Heart failure, strict

2.35

1.43

1.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.32

1.42

1.0

1.1

—

Allergic rhinitis

3.09

1.42

1.2

1.1

—

Recurrent or chronic depression

2.81

1.41

1.2

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.84

1.41

1.0

1.1

—

Heart failure and antihypertensive medication

3.27

1.41

1.0

—

Lumbar disc prolapse

2.30

1.41

1.0

1.1

—

Sequelae of cerebrovascular disease

2.72

1.41

1.2

1.0

—

Disorders of sclera, cornea, iris and ciliary body

2.17

1.39

1.1

1.0

—

Cardiac arrhythmias

2.53

1.39

1.0

—

Infections with a predominantly sexual mode of transmission

2.66

1.38

1.0

1.1

—

Non-ischemic cardiomyopathy

2.68

1.37

1.0

—

Other enthesopathies

2.61

1.36

1.0

1.1

—

Intracranial injury

2.18

1.35

1.0

1.1

—

Gastroduodenal ulcer

2.93

1.35

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

2.02

1.34

1.1

—

Disorders of conjunctiva

1.93

1.32

1.1

—

Degeneration of macula and posterior pole

2.45

1.31

1.1

—

Viral infections characterized by skin and mucous membrane lesions

1.92

1.30

1.0

1.1

—

Excessive attrition of teeth

2.09

1.30

1.0

1.1

—

Zoster [herpes zoster]

2.39

1.30

1.0

1.1

—

Pain in limb

2.01

1.29

1.0

1.1

—

Obesity due to excess calories

2.35

1.29

1.0

1.1

—

Asthma/COPD (KELA code 203)

1.88

1.28

1.1

1.0

—

Valvular heart disease excluding rheumatic fever

2.31

1.26

1.0

1.1

—

Non-rheumatic valve diseases

2.31

1.26

1.0

1.1

—

Certain infectious and parasitic diseases

2.36

1.26

1.0

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2.27

1.26

1.0

—

Acute suppurative otitis media

2.74

1.26

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

2.20

1.24

1.1

—

Obesity

2.02

1.24

1.0

1.1

—

2.39

1.22

1.3

1.0

—

Inflammatory bowel disease

2.63

1.21

1.0

1.1

—

Vasomotor and allergic rhinitis

2.36

1.21

1.2

1.1

—

Other nutritional deficiencies

2.05

1.21

1.0

1.1

—

Acute bronchitis

2.35

1.21

1.0

1.1

—

Substance abuse

2.04

1.21

1.1

1.0

—

Internal derangement of knee

2.30

1.18

1.2

1.1

—

Mental and behavioural disorders due to psychoactive substance use

2.01

1.16

1.1

1.0

—

Chronic periodontitis, including avohilmo

1.80

1.15

1.1

1.0

—

Periodontitis

1.80

1.14

1.1

1.0

—

Nutritional anaemias

2.33

1.12

1.0

—

Parasetamol

2.36

1.12

1.0

1.1

—

Actinic keratosis

2.44

1.11

1.4

1.0

—

Hypothyroidism, strict autoimmune

2.30

1.11

1.0

1.1

—

Other headache syndromes

2.38

1.09

1.0

—

Other diseases of pleura

2.19

1.08

1.1

1.0

—

Diseases of inner ear

1.93

1.07

1.1

—

Hallux valgus (acquired)

2.40

1.06

1.2

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.73

1.05

1.1

—

Coxarthrosis [arthrosis of hip](FG)

2.14

1.05

1.0

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.10

1.04

1.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

2.31

1.04

1.4

1.0

—

All anxiety disorders

1.98

1.04

1.1

—

Diseases of liver

2.27

1.03

1.0

1.1

—

Alcohol use disorder, ICD-based

2.06

1.02

1.0

—

Statin medication

1.95

1.02

1.1

1.0

—

Noninfective enteritis and colitis

2.06

1.02

1.0

1.1

—

Alcohol use disorder, Swedish definition

1.92

1.02

1.0

1.1

—

Acute sinusitis

2.02

1.01

1.1

—

Acute upper respiratory infections

1.72

1.00

1.1

—

Other heart diseases, wide

1.77

1.00

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.00

1.00

1.1

—

Tonsillectomy and adenotomy

2.03

0.99

1.0

—

Urticaria and erythema

2.17

0.98

1.0

—

Myocardial infarction, strict

1.99

0.98

1.1

1.0

—

Meniscus derangement

1.96

0.96

1.1

—

Sensorineural hearing loss

1.82

0.95

1.1

—

Dementia, including avohilmo

2.29

0.95

1.0

1.1

—

1.76

0.93

1.0

1.1

—

Appendicitis, broad definition

1.78

0.93

1.1

—

Antihypertensive medication - note that there are other indications

2.02

0.92

1.0

—

Diseases of appendix

1.77

0.92

1.1

—

External causes of morbidity and mortality

2.00

0.92

1.0

1.1

—

Malignant neoplasm of skin

2.16

0.91

1.2

1.1

—

Iron deficiency anaemia

2.11

0.90

1.0

—

Sciatica+with lumbago

2.04

0.88

1.0

1.1

—

Disorders of vestibular function (Vertigo)

2.03

0.88

1.2

1.0

—

Conductive and sensorineural hearing loss

1.77

0.87

1.1

—

Neurotic, stress-related and somatoform disorders

1.71

0.87

1.1

1.0

—

Anxiety disorders

1.71

0.86

1.1

1.0

—

Major coronary heart disease event excluding revascularizations

1.84

0.86

1.1

—

Mental and behavioural disorders due to alcohol

1.83

0.86

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.81

0.85

1.0

1.1

—

Myocardial infarction, without ST-elevation

1.95

0.84

1.2

1.0

—

Conjunctivitis

1.78

0.84

1.1

—

Chronic periodontitis, complicated

1.76

0.83

1.1

—

Anxiety (asthma-related co-morbidities)

1.77

0.83

1.1

—

Depression or dysthymia

1.77

0.82

1.1

—

Periapical abscess

1.88

0.81

1.0

1.1

—

Caries of enamel

1.66

0.81

1.1

1.0

—

Exposure to other specified factors

1.68

0.80

1.1

—

Gastro-oesophageal reflux disease

1.68

0.79

1.0

1.1

—

Injuries to the thorax

1.82

0.79

1.0

1.1

—

Unspecified fall

1.79

0.77

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

1.74

0.77

1.0

1.1

—

Transient ischemic attack

1.80

0.77

1.0

1.1

—

Sleep disorders (combined)

1.60

0.77

1.1

1.0

—

Other specific joint derangements/joint disorders

1.71

0.76

1.0

1.1

—

Disorders of skin appendages

1.76

0.76

1.3

1.0

—

Pain in joint

1.94

0.76

1.0

1.1

—

Unspecific neurodegenerative disorder

2.14

0.75

1.0

—

Abnormalities of heart beat

2.13

0.75

1.0

1.1

—

Glaucoma suspect

2.08

0.74

1.0

1.1

—

Disorders of the thyroid gland

1.63

0.74

1.0

1.1

—

Diseases of the respiratory system

1.85

0.74

1.0

1.1

—

Myocardial infarction

1.82

0.73

1.1

1.0

—

Disorders of vitreous body

1.83

0.73

1.0

1.1

—

Chronic apical periodontitis

1.56

0.73

1.1

—

Anxiety disorders, excluding more controls

1.71

0.73

1.1

—

Suppurative and unspecified otitis media

2.01

0.73

1.0

—

Injury of muscle and tendon at shoulder and upper arm level

2.00

0.72

1.0

—

Allergic conjunctivitis

1.79

0.72

1.1

—

Heart failure and bmi 25plus

1.99

0.71

1.0

1.1

—

Disorders of vitreous body and globe

1.77

0.71

1.0

1.1

—

Acute appendicitis

1.67

0.71

1.1

—

Persons encountering health services for examination and investigation

1.75

0.71

1.0

1.1

—

Irregular menses

1.88

0.69

1.0

—

Diaphragmatic hernia

1.85

0.68

1.0

1.1

—

Presence of cardiac and vascular implants and grafts

1.86

0.68

1.0

1.1

—

Disorders of synovium and tendon

1.66

0.68

1.0

1.1

—

Coxarthrosis, primary

1.65

0.67

1.0

1.1

—

Glaucoma

1.63

0.66

1.0

1.1

—

Opioids

1.63

0.66

1.0

1.1

—

Basal cell carcinoma, including avohilmo

1.81

0.66

1.2

1.1

—

Use of hypnotics and sedatives

1.52

0.65

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.60

0.65

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.78

0.65

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.59

0.65

1.1

—

Diseases of the skin and subcutaneous tissue

1.58

0.65

1.2

1.0

—

Heart failure and coronary heart disease

1.77

0.64

1.0

—

Mood disorders, excluding more controls

1.60

0.64

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.57

0.64

1.1

—

Constipation

1.59

0.63

1.0

1.1

—

Other and unspecified disorders of vitreous body

1.70

0.63

1.0

1.1

—

Disorders of breast

1.68

0.62

1.2

1.0

—

Appendectomy

1.63

0.62

1.1

1.0

—

Dorsopathies

1.60

0.61

1.0

1.1

—

1.61

0.61

1.0

1.1

—

Coronary artery bypass grafting

0.00

0.61

0.0

1.0

—

Chronic diseases of tonsils and adenoids

1.58

0.61

1.0

1.1

—

Examination and observation for other reasons

1.83

0.60

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

1.54

0.59

1.3

1.0

—

Accidents

1.54

0.59

1.0

—

Other external causes of accidental injury

1.54

0.59

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.54

0.59

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

1.51

0.58

1.0

1.1

—

Coxarthrosis

1.72

0.58

1.0

1.1

—

Dental operations

1.71

0.58

1.0

1.1

—

Peripheral artery disease

1.71

0.57

1.0

—

Cystitis

1.53

0.55

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

1.62

0.55

1.0

1.1

—

Complications of procedures, not elsewhere classified

1.52

0.55

1.0

1.1

—

Artificial joint operation, meniscal resection

1.52

0.54

1.2

1.0

—

Shoulder lesions

1.47

0.54

1.0

1.1

—

Benzodiazepine use

1.47

0.53

1.1

—

Ischemic heart diseases

1.42

0.52

1.1

—

Excessive earwax

1.50

0.51

1.0

1.1

—

Hypothyroidism, other/unspecified

1.53

0.51

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.59

0.50

1.0

1.1

—

Diseases of the eye and adnexa

1.59

0.50

1.0

1.1

—

Medical abortion

1.58

0.50

1.0

1.1

—

Gonarthrosis

1.53

0.49

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.49

0.48

1.0

1.1

—

Other arrhythmias

1.39

0.44

1.0

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.38

0.44

1.0

1.1

—

Unspecified haematuria

1.66

0.43

1.2

1.0

—

Other menopausal disorders

0.00

0.43

0.0

1.0

—

Polyp of the female genital tract

0.00

0.42

0.0

1.0

—

Injuries to the hip and thigh

1.56

0.42

1.2

1.1

—

Injuries to the shoulder and upper arm

1.44

0.41

1.0

1.1

—

Complications predominantly related to the puerperium

0.00

0.41

0.0

1.1

—

Injuries to the ankle and foot

1.37

0.41

1.0

1.1

—

Coxarthrosis, primary, with hip surgery

1.51

0.41

1.0

1.1

—

Gastrointestinal diseases

1.47

0.40

1.0

—

Soft tissue disorders

1.42

0.39

1.0

1.1

—

Other arthrosis

1.44

0.39

1.0

1.1

—

Ischaemic heart disease, wide definition

1.39

0.39

1.1

—

Emergency coronary revascularization (for ACS)

1.37

0.39

1.1

—

L02BG Aromatase inhibitors

0.00

0.39

0.0

1.1

—

Mood [affective] disorders

1.36

0.38

1.1

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.52

0.37

1.0

1.1

—

Mood disorders

1.36

0.37

1.1

1.0

—

Gonarthrosis,primary

1.29

0.37

1.1

—

Bleeding

1.39

0.36

1.0

1.1

—

Benign neoplasm: Colon

1.40

0.35

1.0

1.1

—

Angina pectoris

1.38

0.35

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

1.35

0.34

1.2

1.0

—

Depression

1.35

0.34

1.1

1.0

—

Dermatophytosis

1.33

0.33

1.0

1.1

—

Diverticular disease of intestine

1.32

0.33

1.2

1.1

—

Carpal tunnel syndrome

1.32

0.33

1.0

1.1

—

Fall on same level involving ice and snow

1.30

0.33

1.0

1.1

—

Arthrosis

1.37

0.32

1.0

1.1

—

Other disorders of ear

1.36

0.32

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

1.32

0.31

1.1

—

Percutaneous Coronary Intervention

1.32

0.29

1.1

—

Coronary revascularization (ANGIO or CABG)

1.32

0.29

1.1

—

Major coronary heart disease event

1.27

0.28

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.26

0.28

1.0

1.1

—

Exposure to unspecified factor

1.30

0.27

1.1

1.0

—

Abnormal findings on examination of blood, without diagnosis

1.35

0.23

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.32

0.23

1.0

1.1

—

Postmenopausal atrophic vaginitis

0.00

0.22

0.0

1.0

—

Other maternal disorders predominantly related to pregnancy

1.21

0.22

1.0

1.1

—

Acute appendicitis, no complications

1.21

0.22

1.0

—

Long labour

0.00

0.21

0.0

1.0

—

Triptan medication for migraine, min. 3 purchases

1.19

0.21

1.0

1.1

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

1.18

0.21

1.2

1.1

—

Other hammer toe(s) (acquired)

0.00

0.21

0.0

1.1

—

Endometriosis ASRM stages 3,4

0.00

0.21

0.0

1.1

—

Neoplasms

1.27

0.21

1.0

—

Impacted teeth

0.00

0.20

0.0

1.0

—

Coronary atherosclerosis

1.27

0.20

1.2

1.1

—

Ganglion

0.00

0.20

0.0

1.1

—

Selective serotonin reuptake inhibitors

1.24

0.18

1.1

—

Artrosis, including avohilmo

1.15

0.17

1.0

1.1

—

Insomnia

1.12

0.16

1.0

1.1

—

Benign neoplasms

1.18

0.16

1.0

—

Hernia

1.14

0.15

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

0.80

0.15

1.0

1.1

—

Varicose veins

1.11

0.10

1.0

1.1

—

Diseases of pulp and periapical tissues and dental caries

1.07

0.09

1.0

1.1

—

Pregnancy with abortive outcome

1.04

0.09

1.0

1.1

—

Triptan medication for migraine, single purchase ok

0.77

0.08

1.0

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.77

0.08

1.0

1.1

—

Dental pulpitis, including avohilmo

1.06

0.07

1.0

1.1

—

Injuries to the wrist and hand

0.88

0.07

1.1

1.0

—

Diseases of the ear and mastoid process

1.10

0.05

1.1

—

Perineal laceration during delivery

0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Other disorders of the genitourinary system

0.00

0.0

1.0

—

Other joint disorders

0.90

0.00

1.0

1.1

—

Macular pucker

0.00

0.0

1.0

—

Other diseases of oesophagus

0.00

0.0

1.0

—

Acne

0.00

0.0

1.0

—

Emotionally unstable personality disorder

0.00

0.0

1.0

—

Presbycusis

0.00

0.0

1.0

—

Injuries to the elbow and forearm

0.84

0.00

1.0

1.1

—

Dilated cardiomyopathy

0.00

0.0

1.0

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.0

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

-0.00

0.0

1.0

—

Thyroiditis, ILD-related definition

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at wrist and hand level

0.00

-0.00

0.0

1.0

—

Idiopathic gout

0.00

-0.00

0.0

1.0

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.0

—

Endometriosis of ovary

0.00

-0.00

0.0

1.0

—

Vitamin B12 deficiency anaemia

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.2

—

Chronic pancreatitis

0.00

-0.00

0.0

1.0

—

Other diseases of pancreas

0.00

-0.00

0.0

1.0

—

Ascites

0.00

-0.00

0.0

1.0

—

Pain in thoracic spine

0.00

-0.00

0.0

1.0

—

Caries of dentine, including avohilmo

1.02

-0.00

1.0

1.1

—

Crowding of teeth, including avohilmo

0.00

-0.00

0.0

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

-0.00

0.0

1.0

—

Lichen sclerosus et atrophicus

0.00

-0.00

0.0

1.0

—

Ménière disease

0.00

-0.00

0.0

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.95

-0.00

1.0

1.1

—

Foreign body on external eye

0.00

-0.00

0.0

1.1

—

Superficial injury of shoulder and upper arm

0.00

-0.00

0.0

1.0

—

Premature rupture of membranes

0.00

-0.00

0.0

1.0

—

Sleep disorders

1.00

-0.00

1.0

1.1

—

Puerperal sepsis

0.00

-0.00

0.0

1.1

—

Complications of labour and delivery

1.03

-0.00

1.0

1.1

—

Otitis media, unspecified

0.00

-0.00

0.0

1.0

—

Early lumbar disc prolapse operation

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of upper limb

0.00

-0.00

0.0

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.97

-0.00

1.0

1.1

—

Postpartum haemorrhage due to retained placenta

0.00

-0.00

0.0

1.0

—

Disorder of lipoprotein metabolism, unspecified

0.00

-0.00

0.0

1.0

—

Non-allergic asthma (mode), excluding more controls

0.00

-0.00

0.0

1.0

—

Superficial injury of thorax

0.00

-0.00

0.0

1.0

—

Abdominal aortic aneurysm (AAA)

0.00

-0.00

0.0

1.0

—

Valvular operations

0.00

-0.00

0.0

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

1.0

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

1.0

—

Arthropathies

1.01

-0.00

1.0

1.1

—

Benign neoplasm of meninges

0.00

-0.00

0.0

1.0

—

Allergic contact dermatitis

0.00

-0.00

0.0

1.0

—

Other benign neoplasms of connective and other soft tissue

0.00

-0.00

0.0

1.0

—

Other disorders of amniotic fluid and membranes

0.00

-0.00

0.0

1.0

—

Cardiomyopathies, Primary/intrinsic

0.00

-0.00

0.0

1.0

—

Non-allergic asthma (mode)

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.0

—

Atrophic disorders of skin

0.00

-0.00

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

-0.00

0.0

1.0

—

Amiodarone users

0.00

-0.00

0.0

1.0

—

Inguinal hernia

1.01

-0.00

1.0

—

Prolonged pregnancy

0.00

-0.00

0.0

1.0

—

Other/unspecified synovitis and tenosynovitis

0.00

-0.00

0.0

1.0

—

HSIL lesion of the cervix uteri

0.00

-0.00

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

-0.00

0.0

1.0

—

Nonischemic cardiomyopathy

0.00

-0.00

0.0

1.0

—

Dental caries, including avohilmo

0.98

-0.00

1.0

1.1

—

Assault by bodily force

0.00

-0.00

0.0

1.0

—

Other local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Acute nasopharyngitis (common cold)

0.00

-0.00

0.0

1.1

—

Superficial injury of ankle and foot

0.00

-0.00

0.0

1.0

—

Other female pelvic inflammatory diseases

0.00

-0.00

0.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

-0.00

0.0

1.0

—

Coeliac disease

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS